Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003188162 | SCV003868947 | likely benign | Cardiovascular phenotype | 2023-02-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004009662 | SCV004823915 | likely benign | Catecholaminergic polymorphic ventricular tachycardia | 2023-02-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005101185 | SCV005822129 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2024-10-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004538917 | SCV004748183 | likely benign | RYR2-related disorder | 2023-08-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |